Browsing by Author "Henriques, A."
Now showing 1 - 5 of 5
Results Per Page
Sort Options
- Combined Pancreas-Kidney Transplantation: A New Program in Portugal, Results From the First 12 CasesPublication . Martins, L.; Henriques, A.; Dias, L.; Ventura, A.; Seca, R.; Almeida, R.; Dores, J.; Bacelar, C.; Oliveira, F.; Lhamas, A.; Amil, M.; Rua, F.; Coelho, T.; Esteves, S.; Ribeiro, A.; Pereira, R.; Sarmento, A.; Teixeira, M.; Pereira, M.Transplant Proc. 2003 May;35(3):1107-8. Combined pancreas-kidney transplantation: a new program in Portugal, results from the first 12 cases. Martins L, Henriques A, Dias L, Ventura A, Seca R, Almeida R, Dores J, Bacelar C, Oliveira F, Lhamas A, Amil M, Rua F, Coelho T, Esteves S, Ribeiro A, Pereira R, Sarmento A, Teixeira M, Pereira M. Transplantation Department, Hospital Santo António, 4050, Porto, Portugal. lasalete@clix.pt PMID: 12947877 [PubMed - indexed for MEDLINE]
- Histiocytic sarcoma; case report of a rare disease in a kidney transplant recipientPublication . Ventura Aguiar, P.; Dias, C.; Azevedo, P.; Silva, H.; Almeida, M.; Pedroso, S.; Martins, L.; Dias, L.; Rodrigues, A.; Viscaíño, R.; Cabrita, A.; Henriques, A.BACKGROUND: Histiocytic sarcoma (HS) is a rare hematologic neoplasm with a few hundred cases having been described to date.
- Long-Term Complications After Renal TransplantationPublication . Martins, L.; Ventura, A.; Costa, S.; Henriques, A.; Dias, L.; Sarmento, A.IN the past, every effort was directed at the prevention of acute rejection in renal transplant (RT) patients (pts). Ever since the introduction of the new immunosuppressive agents in the late 1990s, the short-term results of renal graft survival are considered satisfactory. In recent years, the prevention of long-term graft loss and the extension of life expectancy have gained new emphasis. The immunosuppressive agents though, namely calcineurin-inhibitors and steroids, may potentiate the development of several problems in RT pts: obesity, hyperglycemia, hyperlipidemia, and hypertension,1 which are not only risk factors for cardiovascular disease but also for graft loss.2,3 We performed a retrospective analysis of all RTs performed at our unit that reached 10 years (y) with a functioning graft. The aim of the study was to evaluate long-term complications and, in view of the results, to seek a possible strategy that minimizes these problems.
- Steroid Withdrawal in Simultaneous Pancreas-Kidney Transplantation:Publication . Malheiro, J.; Martins, La Salete; Fonseca, Isabel; Gomes, A.M.; Santos, J.; Dias, L.; Dores, J.; Oliveira, F.; Seca, R.; Almeida, R.; Henriques, A.; Cabrita, A.; Teixeira, M.ABSTRACT Simultaneous pancreas-kidney transplantation (SPK) is the treatment of choice for selected diabetic patients with end-stage renal disease. Maintenance steroid therapy is associated with significant morbidity and mortality among SPK transplant recipients. Steroid withdrawal regimens are becoming more common, albeit with reservations regarding its safety and efficacy. We performed retrospective review of 77 SPK transplant recipients from May 2000 to December 2007. The subjects received induction therapy with thymoglobulin followed by maintenance immunosuppression with tacrolimus and myco- phenolate mofetil. late steroid withdrawal protocol was adopted. The rates of acute rejection, graft and patient survival, and side effects were analyzed. One-year patient, kidney, and pancreas survivals were 93%91%and 86%respectively. Eleven patients experienced acute rejection. Mean follow-up time was 1155.5 776.1 days. Prednisolone withdrawal was carried out between and 12 months posttransplantation in 42 patients (77.8%with at least year follow-up; no case of acute rejection occurred. At present, 72 patients have functioning kidney graft, and 65 patients also have functioning pancreas graft. The mean serum creatinine is 1.12 0.49 mg/dL and the mean HbA1c concentration is 4.5% 0.4%The patients have low prevalence of hypertension, hyperlipidemia, and obesity. Steroid withdrawal was successful and safe in the majority of in-study patients and safe without an increase of immune events. Our patient and graft outcomes are within other international SPK transplant units standards.
- "Very urgent" kidney transplantation: results from one center.Publication . Costa, S.; Ventura, A.; Costa, T.; Martins, L.; Henriques, A.; Sarmento, A.Transplant Proc. 2003 May;35(3):1066. "Very urgent" kidney transplantation: results from one center. Costa S, Ventura A, Costa T, Martins L, Henriques A, Sarmento A. Nephrology Department, Hospital de Santo António, 4050 Porto, Portugal. PMID: 12947858 [PubMed - indexed for MEDLINE]